Related Experiment Video
Updated: Apr 10, 2026

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus
Published on: April 19, 2017
Fingolimod-associated cryptococcal meningitis in a patient with Multiple Sclerosis: A case report and literature
Hidenori Nakagawa1, Akari Takagi2, Takahiro Mitsueda2
1Department of Infectious Diseases, Osaka City General Hospital, Osaka, Japan.
Abstract:
A 65-year-old woman with Multiple Sclerosis treated with fingolimod developed headaches and convulsions. Cerebrospinal fluid (CSF) culture indicated Cryptococcus neoformans. A literature review of 20 cases of cryptococcal meningitis indicated that headache was the most common initial symptom, and all cases were positive for serum and/or CSF cryptococcal antigens.
Insights
Fingolimod treatment for Multiple Sclerosis can lead to cryptococcal meningitis, a serious infection. Early symptoms include headaches, and diagnosis relies on detecting Cryptococcus neoformans antigens in cerebrospinal fluid.
Area of Science:
- Neurology
- Infectious Diseases
- Immunology
Background:
- Multiple Sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
- Fingolimod is an immunomodulatory drug used to treat relapsing forms of MS.
- Immunosuppression increases the risk of opportunistic infections, including fungal meningitis.
Observation:
- A 65-year-old woman with MS on fingolimod presented with headaches and convulsions.
- Cerebrospinal fluid (CSF) analysis revealed Cryptococcus neoformans.
- A literature review identified 20 similar cases of cryptococcal meningitis.
Findings:
- Headache was the most frequent initial symptom in cryptococcal meningitis cases.
- All reviewed cases tested positive for serum and/or CSF Cryptococcus neoformans antigens.
- Fingolimod-treated patients may be at increased risk for this opportunistic infection.
Implications:
- Clinicians should consider cryptococcal meningitis in MS patients on fingolimod presenting with neurological symptoms.
- Prompt diagnosis via antigen testing is crucial for effective treatment.
- Monitoring for opportunistic infections is essential in patients receiving immunosuppressive therapies for MS.
More Related Videos
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Fungal Phylum Microsporidia
Cytomegalovirus Disease

